CN1321089A - 增加肠吸收脂肪的方法和组合物 - Google Patents

增加肠吸收脂肪的方法和组合物

Info

Publication number
CN1321089A
CN1321089A CN99811075A CN99811075A CN1321089A CN 1321089 A CN1321089 A CN 1321089A CN 99811075 A CN99811075 A CN 99811075A CN 99811075 A CN99811075 A CN 99811075A CN 1321089 A CN1321089 A CN 1321089A
Authority
CN
China
Prior art keywords
lysolecithin
fatty acid
isolated complex
monoglyceride
molar ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99811075A
Other languages
English (en)
Chinese (zh)
Inventor
戴维·W·耶萨尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomolecular Products Inc
Original Assignee
Biomolecular Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomolecular Products Inc filed Critical Biomolecular Products Inc
Publication of CN1321089A publication Critical patent/CN1321089A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01004Phospholipase A2 (3.1.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN99811075A 1998-09-08 1999-09-07 增加肠吸收脂肪的方法和组合物 Pending CN1321089A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9943098P 1998-09-08 1998-09-08
US60/099,430 1998-09-08

Publications (1)

Publication Number Publication Date
CN1321089A true CN1321089A (zh) 2001-11-07

Family

ID=22274976

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99811075A Pending CN1321089A (zh) 1998-09-08 1999-09-07 增加肠吸收脂肪的方法和组合物

Country Status (13)

Country Link
US (1) US6426069B1 (https=)
EP (1) EP1119360B1 (https=)
JP (1) JP4700193B2 (https=)
CN (1) CN1321089A (https=)
AT (1) ATE347371T1 (https=)
AU (1) AU771901B2 (https=)
CA (1) CA2343116C (https=)
DE (1) DE69934325T2 (https=)
IL (2) IL141801A0 (https=)
NO (1) NO20011173L (https=)
NZ (1) NZ510536A (https=)
WO (1) WO2000013689A1 (https=)
ZA (1) ZA200102268B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103179990A (zh) * 2010-10-22 2013-06-26 学校法人福冈大学 应用了对胃上皮性肿瘤(腺瘤、胃癌)的诊断有用的白色不透明物质的内窥镜观察法及诊断能力改善组合物
WO2025148196A1 (zh) * 2024-01-12 2025-07-17 小藻科技(安吉)有限公司 一种促进脂肪酸吸收及跨越血脑屏障的微藻提取物及其组合物的应用

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1434593B1 (en) * 2001-10-11 2017-03-29 Biomolecular Products, Inc. MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
ES2355890T3 (es) 2002-04-05 2011-04-01 Societe des Produits Nestlé S.A. Composiciones y métodos para promocionar la asimilación de lípidos en los animales domésticos.
DE10217555A1 (de) * 2002-04-19 2004-02-19 Degussa Bioactives Deutschland Gmbh Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix
CA2513260C (en) * 2003-01-31 2013-01-08 Childrens Hospital Los Angeles Oral compositions of fenretinide having increased bioavailability and methods of using the same
US7758884B2 (en) * 2005-01-28 2010-07-20 Kemin Industries, Inc. Formulation for increasing the deposition of dietary carotenoids in eggs
EP1688049A1 (de) * 2005-02-03 2006-08-09 findusFit Sportdiätetika GmbH Diätetisches Lebensmittel
FR2918846B1 (fr) * 2007-07-20 2013-07-26 Isl Innovation Sante Lipides Composition alimentaire pour ameliorer la digestibilite des lipides alimentaires
US20120121691A1 (en) * 2010-11-15 2012-05-17 Texas Tech University System Method for Increasing the Production of a Specific ACYL-Chain Dihydroceramide(s) for Improving the Effectiveness of Cancer Treatments
AU2019342421B2 (en) * 2018-09-21 2024-09-05 Société des Produits Nestlé S.A. Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4849132A (en) 1986-05-16 1989-07-18 Asahi Denka Kogyo Kabushiki Kaisha Surfactant composition having improved functions
US5571517A (en) 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
CA2089003C (en) 1990-08-13 2001-03-20 David W. Yesair Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
DE69614855T2 (de) * 1995-06-06 2002-03-28 Biomolecular Products, Inc. Gemischte lipid-bicarbonat kolloidale partikel zur abgabe von arzneistoffen oder kalorien
US5716814A (en) 1996-02-02 1998-02-10 Biomolecular Products, Inc. Methods for making lysophosphatidylcholine
DE69739482D1 (de) * 1996-09-11 2009-08-13 Elizabeth Shanahan-Prendergast Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103179990A (zh) * 2010-10-22 2013-06-26 学校法人福冈大学 应用了对胃上皮性肿瘤(腺瘤、胃癌)的诊断有用的白色不透明物质的内窥镜观察法及诊断能力改善组合物
CN103179990B (zh) * 2010-10-22 2015-02-04 学校法人福冈大学 应用了对胃上皮性肿瘤(腺瘤、胃癌)的诊断有用的白色不透明物质的内窥镜观察法及诊断能力改善组合物
WO2025148196A1 (zh) * 2024-01-12 2025-07-17 小藻科技(安吉)有限公司 一种促进脂肪酸吸收及跨越血脑屏障的微藻提取物及其组合物的应用

Also Published As

Publication number Publication date
JP4700193B2 (ja) 2011-06-15
NZ510536A (en) 2003-07-25
ATE347371T1 (de) 2006-12-15
ZA200102268B (en) 2001-09-19
NO20011173D0 (no) 2001-03-07
DE69934325D1 (de) 2007-01-18
EP1119360A1 (en) 2001-08-01
EP1119360A4 (en) 2003-06-04
NO20011173L (no) 2001-05-08
WO2000013689A1 (en) 2000-03-16
AU5705299A (en) 2000-03-27
US6426069B1 (en) 2002-07-30
CA2343116A1 (en) 2000-03-16
JP2002524417A (ja) 2002-08-06
AU771901B2 (en) 2004-04-08
CA2343116C (en) 2008-11-18
DE69934325T2 (de) 2007-07-05
EP1119360B1 (en) 2006-12-06
IL141801A (en) 2009-02-11
IL141801A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
US20230047556A1 (en) Anti-inflammatory properties of marine lipid compositions
CN1268328C (zh) 辅酶q与二十碳五烯酸(epa)
WO2008149177A2 (en) Marine lipid compositions and uses thereof
CN1684677A (zh) 用于增强认知能力的含有花生四烯酸或其与二十二碳六烯酸的组合的组合物
US20120116104A1 (en) Mixtures of and methods of use for polyunsaturated fatty acid-containing phospholipids and alkyl ether phospholipids species
CN1516592A (zh) 用于预防和/或治疗心血管疾病、关节炎、皮肤癌、糖尿病、经前综合症和透皮转运的磷虾和/或海产提取物
JPH08193028A (ja) ヘリコバクターの阻害
CN1321089A (zh) 增加肠吸收脂肪的方法和组合物
CN1774443A (zh) 仲醇磷酸盐
US20080058286A1 (en) Novel applications of omega-3 rich phospholipids
WO2000009138A1 (en) Nutritional compositions for preventing or treating hyperlipoproteinemia
CN1248264A (zh) 特异性胰脂酶抑制剂及其应用
US7842679B2 (en) Phospholipid derivatives of DHA and methods for treating respiratory failure using the same
WO2025148196A1 (zh) 一种促进脂肪酸吸收及跨越血脑屏障的微藻提取物及其组合物的应用
JPH06271464A (ja) 消化器系障害の予防または治療用アラキドン酸含有組成物
US12576059B2 (en) Methods and compositions for treatment of inflammatory disease
US20200085774A1 (en) Omega-3 Fatty Acid Composition for Preventing and/or Treating Cachexia
HK1068284A (en) Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
HK1005224A1 (en) Use of complex lipide as stabilizing additives in pharmaceutical formulation of digestive enzyme mixture
HK1005224B (en) Use of complex lipide as stabilizing additives in pharmaceutical formulation of digestive enzyme mixture

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication